Dec. 6 (UPI) — Pharmaceutical firm Pfizer announced Wednesday it will begin advertising a generic edition of its erectile dysfunction drug Viagra.

Beginning Monday, Pfizer will offer a generic edition of sildenafil, the compound known by the brand name Viagra, in the United States for 50 percent the $65-per-pill retail value of the name-brand pill.

The new generic brand of sildenafil will use white tablets to differentiate by itself from Viagra’s “little blue pill.”

Viagra’s patent doesn’t expire right until 2020, but 4 years back Pfizer agreed to allow Teva Pharmaceutical Industries Ltd. to offer a generic edition of the drug beginning in December 2017 as portion of a lawful settlement.

Pfizer introduced Viagra in March 1998 when it learned sildenafil, a failed angina medicine, brought about guys to get sustained erections.

Britain’s Medications and Health care merchandise Regulatory Company announced last month the erectile dysfunction medicine will be offered for acquire above the counter beginning spring 2018.



Resource connection

LEAVE A REPLY

Please enter your comment!
Please enter your name here